The host immune response to tuberculosis (Q41727902)

8 October 2017

1 reference

title

The host immune response to tuberculosis (English)

1 reference

8 October 2017

0 references

Schluger NW

1

1 reference

8 October 2017

Rom WN

series ordinal

2

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

American Journal of Respiratory and Critical Care Medicine

8 October 2017

published in

1 reference

8 October 2017

volume

157

1 reference

8 October 2017

issue

3 Pt 1

1 reference

8 October 2017

page(s)

679-691

1 reference

Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Improved outcomes for patients with multidrug-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

A new perspective on John Snow's communicable disease theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Prophylaxis with isoniazid in inactive tuberculosis. A Veterans Administration Cooperative Study XII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Interferon-gamma depresses binding of ligand by C3b and C3bi receptors on cultured human monocytes, an effect reversed by fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Phagolysosome Formation, Cyclic Adenosine 3':5'-Monophosphate and the Fate of Salmonella typhimurium within Mouse Peritoneal Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Virulence and Resistance to Superoxide, Low pH and Hydrogen Peroxide among Strains of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Identification of nitric oxide synthase as a protective locus against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Dormancy ofMycobacterium tuberculosis and latency of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Differential effects of cytolytic T cell subsets on intracellular infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Tumor necrosis factor alpha (TNFalpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNFalpha from iron-treated infected monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Disseminated tuberculosis in interferon gamma gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Pleiotropic effects of transforming growth factor-beta on cells of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

The role of T cell--macrophage interactions in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Genetics and resistance to tuberculosis. Could resistance be enhanced by genetic engineering?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

The origin and erratic global spread of tuberculosis. How the past explains the present and is the key to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Evidence for exclusion of a mutation in NRAMP as the cause of familial disseminated atypical mycobacterial infection in a Maltese kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Th1-Th2 paradigm: insights from leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

TH2-type cytokines in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Interleukin 12 at the site of disease in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Clinical correlates of interferon gamma production in patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Antigenic specificity and subset analysis of T cells isolated from the bronchoalveolar lavage and pleural effusion of patients with lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Relation of bronchoalveolar lavage T lymphocyte subpopulations to rate of regression of active pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Evidence for an alpha/beta T cell-independent mechanism of resistance to mycobacteria. Bacillus-Calmette-Guerin causes progressive infection in severe combined immunodeficient mice, but not in nude mice or in mice depleted of CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Gamma/delta T lymphocytes in Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Gamma delta T lymphocytes in human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Contribution of alpha/beta and gamma/delta T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guérin: studies with T cell receptor-deficient mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Enhancement Of Intracellular Growth Of Mycobacterium Tuberculosis In Human Monocytes by Transforming Growth Factor- l

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Ammonia inhibits phagosome–lysosome fusion in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

Killing of Mycobacterium microti by immunologically activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.3.9708002

10.1164/AJRCCM.157.3.9708002

21 January 2018

Identifiers

DOI

1 reference

8 October 2017

1 reference